FSEAX
Price
$62.29
Change
+$0.02 (+0.03%)
Updated
Sep 9 closing price
Net Assets
1.27B
MITEX
Price
$16.93
Change
+$0.18 (+1.07%)
Updated
Sep 9 closing price
Net Assets
308.24M
Interact to see
Advertisement

FSEAX vs MITEX

Header iconFSEAX vs MITEX Comparison
Open Charts FSEAX vs MITEXBanner chart's image
Fidelity Emerging Asia
Price$62.29
Change+$0.02 (+0.03%)
VolumeN/A
Net Assets1.27B
Matthews Asia Innovators Institutional
Price$16.93
Change+$0.18 (+1.07%)
VolumeN/A
Net Assets308.24M
FSEAX vs MITEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSEAX vs. MITEX commentary
Sep 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSEAX is a Buy and MITEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSEAX has more cash in the bank: 1.27B vs. MITEX (308M). FSEAX (0.00) and MITEX (0.00) have matching dividends . FSEAX was incepted earlier than MITEX: FSEAX (32 years) vs MITEX (12 years). MITEX (1.17) is less costly to investors than FSEAX (0.65). MITEX is a more actively managed with annual turnover of: 257.92 vs. FSEAX (57.00). FSEAX has a lower initial minimum investment than MITEX: FSEAX (0) vs MITEX (100000). FSEAX annual gain was more profitable for investors over the last year : 42.71 vs. MITEX (37.63). FSEAX return over 5 years is better than : 1.80 vs. MITEX (-19.03).
FSEAXMITEXFSEAX / MITEX
Total Expense Ratio0.651.1756%
Annual Report Gross Expense Ratio0.651.1756%
Fund Existence32 years12 years-
Gain YTD26.20227.37696%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.27B308M413%
Annual Yield % from dividends0.000.00-
Returns for 1 year42.7137.63114%
Returns for 3 years71.0014.34495%
Returns for 5 years1.80-19.03-9%
Returns for 10 years109.9238.04289%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PHIO2.120.08
+3.92%
Phio Pharmaceuticals Corp
RF27.040.01
+0.04%
Regions Financial Corp
LGND165.86-0.89
-0.53%
Ligand Pharmaceuticals
OBIO2.73-0.02
-0.73%
Orchestra BioMed Holdings
RLAY4.06-0.06
-1.46%
Relay Therapeutics